ArticleAesthetic plastic surgery2026
Robot-Assisted Breast Augmentation.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comments on "Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial".Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic systems are increasingly employed across various surgical fields and are now expanding into breast surgery. However, few studies have explored robotic surgery in aesthetic breast augmentation. Traditional breast augmentation with axillary approach relies on endoscopic assistance but is limited by restricted visualization, operational inflexibility, surgeon fatigue, and a long learning curve.
objectivesThis study introduces robot-assisted transaxillary breast augmentation using the da Vinci single-port (SP) surgical system (Intuitive Surgical, Sunnyvale, CA), which offers high-resolution imaging with adjustable magnification, flexible robotic arms, and gas insufflation to reduce surgeon fatigue.
methodsFrom January 2023 to July 2024, a total of 12 breasts from eight female patients underwent robot-assisted augmentation using the da Vinci SP surgical system. Four patients received bilateral augmentation for aesthetic purposes, while the remaining four underwent direct-to-implant reconstruction after robot-assisted mastectomy, combined with contralateral augmentation.
resultsThe mean total operative time was 89.8 min (range, 74-100 min), including a mean robotic docking time of 67.7 min (range, 51-78 min). Intraoperative bleeding was minimal, and no early postoperative complications occurred. One patient developed lateral implant displacement and bottoming out, requiring revision surgery, presumably linked to mechanical stress from pectoralis muscle contraction by upper extremity strength training in the early postoperative period. All other patients recovered uneventfully without late complications.
conclusionsRobotic surgery addresses the limitations of endoscopic techniques, achieving favorable cosmetic outcomes with minimal, concealed scarring while enhancing surgical precision and safety. This study demonstrates the technical feasibility of a single-port robotic system for mammoplasty and highlights its potential for broader applications in aesthetic surgery. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
42773277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.